Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2012
09/19/2012CN102266464B Chinese medicinal composition for treating periodontitis
09/19/2012CN102145096B Decoction for treating helicobacter pylori-associated gastritis
09/19/2012CN102106925B Medlar polysaccharide and bifidobacterium synbiotic colonic targeting microecological regulator
09/19/2012CN102070691B Metacavir crystal form, preparation method thereof and medicinal composition containing metacavir crystal form
09/19/2012CN102068588B Chinese medicinal preparation for treating hepatopathy and preparation method thereof
09/19/2012CN102058571B Use of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2- naphthalenyl)carbamoyl]benzoic acid in preparing a pharmaceutical for use in prevention and/or treatment of bowel adhesion
09/19/2012CN102028701B Active ingredient composition for treating alcoholic liver injury
09/19/2012CN102018755B Quality detection method of furan lightyellow sophora root berberine tablet
09/19/2012CN101991656B Medicament for treating mouth disease
09/19/2012CN101979595B Dual expression vector for immunostimulatory RNA and HBV target gene silence RNA, construction and application thereof
09/19/2012CN101912456B Novel application of rubus alceaefolius poir total alkaloid
09/19/2012CN101810607B Hepatitis C resistant plant extracts composition
09/19/2012CN101796039B Phenylacetic acid compound
09/19/2012CN101708236B Application of Hedan tablet in treating fatty liver
09/19/2012CN101683411B Application of crab apple extract in preparing hepatic or health-care food
09/19/2012CN101643749B Adeno-associated virus carrier, preparation method thereof and application
09/19/2012CN101537037B Amaranth berberine tablet and preparation method thereof
09/19/2012CN101389352B Agent for treating or preventing digestive ulcer
09/19/2012CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form
09/19/2012CN101011389B Application of arbidol in preparing medicaments for preventing and/or treating hepatitis B
09/18/2012US8268894 Compositions and methods for the treatment of infectious diseases
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268813 Zilpaterol enantiomer compositions and methods of making and using such compositions
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012CA2525486C Composition for lowering the internal lipid
09/18/2012CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
09/18/2012CA2479659C Choline-silicic acid complex with osmolytes and divalent trace elements
09/18/2012CA2405731C Compositions and methods for improving vascular health
09/13/2012WO2012122478A1 Compositions and methods for transplantation of colon microbiota
09/13/2012WO2012121202A1 Tablet-type composition for oral administration and method for producing same
09/13/2012WO2012121095A1 Enteral nutrient
09/13/2012WO2012120475A1 Cinnamomum burmanii extract, extraction process and its use as proton pump down-regulator, enzyme inhibitor, and mucoprotector
09/13/2012WO2012120048A1 Tfeb phosphorylation inhibitors and uses thereof
09/13/2012WO2012120044A1 Tfeb variants and uses thereof
09/13/2012WO2012119941A1 Peptidyl nitrilcompounds as peptidase inhibitors
09/13/2012WO2012119769A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccine
09/13/2012WO2011131203A3 A solid pharmaceutical composition for neutralizing stomach acid
09/13/2012US20120232158 Methods of treating hyperacidic disorders
09/13/2012US20120232149 Solid pharmaceutical compositions containing pregabalin
09/13/2012US20120232137 Use of Bethaneciol for Treatment of Xerostomia
09/13/2012US20120232122 Tricyclic heterocyclic derivatives
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232113 Methods of treating emesis using growth hormone secretagogues
09/13/2012US20120232109 3-substituted sulfonyl piperidine derivative
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232097 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232084 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
09/13/2012US20120232075 Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231999 Peptidic glp-2 agonists
09/13/2012US20120231996 Phalloidin derivatives and methods for their synthesis
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231994 Antagonism of human formyl peptide receptor for treatment of disease
09/13/2012US20120231097 Medicinal composition and usage
09/13/2012US20120231091 Method for Inducing Differentiation of Dental Pulp Cells Into Odontoblasts
09/13/2012US20120231084 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
09/13/2012US20120231078 Method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
09/13/2012US20120231074 Pharmaceutical solid dosage form
09/13/2012US20120231073 Dexlansoprazole compositions
09/13/2012US20120231057 Treatment and prevention of dental pathology in humans and non-human animals
09/13/2012US20120231046 Implant for subcutaneous or intradermal injection
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120230998 Ip-10 antibodies and their uses
09/13/2012US20120230987 Methods for treating conditions associated with c-fms
09/13/2012US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
09/13/2012US20120230973 Lactase preparation
09/13/2012US20120230956 Bifidobacterium longum and functional gi disorders
09/13/2012US20120230955 Arabinoxylans for modulating the barrier function of the intestinal surface
09/13/2012US20120230940 Conditioned cell culture medium compositions and methods of use
09/13/2012US20120230923 Health-Beneficial Preparation and Production Method
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012DE102011013524A1 Gastroprotective agent comprises Exportal, which is 4-O-(beta-galactopyranosyl)-D-glucitomonohydrate)
09/13/2012CA2829385A1 Compositions and methods for transplantation of colon microbiota
09/13/2012CA2828374A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccine
09/13/2012CA2826864A1 Tfeb variants and uses thereof
09/13/2012CA2826674A1 Tfeb phosphorylation inhibitors and uses thereof
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2496247A1 Methods for treating fatty liver disease
09/12/2012EP2496246A2 Composition, method, and kit for alpha-1 proteinase inhibitor
09/12/2012EP2496241A1 Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria
09/12/2012CN102666580A Glycosylated form of antigenic GLP-1 analogue
09/12/2012CN102666535A Imidazole derivatives as aldosterone synthase inhibitors
09/12/2012CN102666500A Seven-membered ring compound and pharmaceutical use therefor
09/12/2012CN102665760A Primary bile acid and secondary bile acid generation regulator
09/12/2012CN102665750A Nutritional composition beneficial to small intestine
09/12/2012CN102665749A Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
09/12/2012CN102665745A Preventing or treating periodontal diseases by herbal extract
09/12/2012CN102665738A Prophylactic composition for influenza infection
09/12/2012CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
09/12/2012CN102665428A Infant formula with probiotics and milk fat globule membrane components
09/12/2012CN102660529A Pepsin intensifier, pepsin composition and application of pepsin intensifier
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 1258